Telomerase Regulation, Cell Cycle, and Telomere Stability in Primitive Hematopoietic Cells
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Low levels of telomerase activity have recently been detected in human primitive hematopoietic cells, however, blood cells exhibit telomere shortening on cell proliferation. This challenging observation led us to study telomerase regulation and telomere length in human hematopoietic progenitor cells from fetal liver (FL), cord blood (CB), peripheral blood (PB), and bone marrow (BM). We found telomerase activity in CD34+/CD38+ cells exceeding levels in CD34+/CD38−, CD34−, and mononuclear cells (P < .05). Baseline telomerase activity was highest in BM (n = 5) CD34+ cells, followed by PB (n = 20), CB (n = 11), and FL (n = 1). Within 48 hours to 72 hours of in vitro culture of CD34+ cells in the presence of cytokines (KL, interleukin-3 [IL-3], IL-6, erythropoietin, granulocyte colony-stimulating factor), telomerase activity was upregulated, peaked after 1 week of culture, and decreased to baseline levels or below detection after 3 to 4 weeks. Stimulation of CD34+ cells with single cytokines resulted in no or minor telomerase upregulation, whereas cytokine combinations resulted in a significant telomerase increase (P < .001). There was a correlation between telomerase activity, cell cycle status by BrdU incorporation, and induction of phosphorylated retinoblastoma protein, CDC2, CDK2, cyclin D1, and cyclin A, but not cyclin E and B1 after 72 hours with multiple (but not single) cytokines. In nonexpanding CD34+ cells, telomerase was low or undetectable. Secondary CD34+ cells showed a reduced ability to upregulate telomerase activity. Antiproliferative cytokines such as transforming growth factor-β1 and high concentrations of all-trans–retinoic acid in cytokine-supported CD34+ cultures downmodulated telomerase activity. Average telomere lengths were 10.4 kbp, 7.4 kbp, and 7.6 kbp in CB, PB, and BM CD34+ cells, respectively. In ex vivo expansion cultures, an average telomeric DNA loss of 1 to 2 kbp over 4 weeks was observed. However, the rate of base pair loss per population doubling was significantly lower during the first 2 weeks, when telomerase was upregulated, than during weeks 3 and 4 of culture. In summary, telomerase is upregulated in response to cytokine-induced proliferation and cell cycle activation in primitive hematopoietic cells. Telomerase is downregulated between weeks 3 and 4 of ex vivo expansion culture linked with decreased proliferation and greater expansion of more mature cell subsets. Our data suggest that telomerase activity in hematopoietic cells reduces, but does not prevent, telomere shortening on proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Structure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.
Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9857 · Cited by 1,132
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
Buchkovich, K., Duffy, L. A., & Harlow, E. (1989) · Cell · doi:10.1016/0092-8674(89)90508-4 · Cited by 995
Resnitzky, D., Gossen, M., Bujard, H., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1669-1679.1994 · Cited by 965
Activation of telomerase in human lymphocytes and hematopoietic progenitor cells
Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., & Yamakido, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3711 · Cited by 853
Structure and variability of human chromosome ends.
de Lange, T., Shiue, L., Myers, R. M., Cox, D. R., Naylor, S. L., Killery, A. M., & Varmus, H. E. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.518 · Cited by 848
Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes.
Vaziri, H., Schächter, F., Uchida, I. A., Wei, L., Zhu, X., Effros, R. B., Cohen, D., & Harley, C. (1993) · PubMed Central · Cited by 810
Resnitzky, D., Gossen, M., Bujard, H., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1669 · Cited by 664
Telomere length and replicative aging in human vascular tissues.
Chang, E., & Harley, C. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11190 · Cited by 636
Correlating telomerase activity levels with human neuroblastoma outcomes
Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., & Shay, J. W. (1995) · Nature Medicine · doi:10.1038/nm0395-249 · Cited by 611
Telomerase activity in normal and malignant hematopoietic cells
Broccoli, D., Young, J. W., & de Lange, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9082 · Cited by 567
Telomerase activity in normal leukocytes and in hematologic malignancies
Counter, C., Gupta, J., Harley, C., Leber, B., & Bacchetti, S. (1995) · Blood · doi:10.1182/blood.v85.9.2315.bloodjournal8592315 · Cited by 477
Telomerase, Cell Immortality, and Cancer
Harley, C. B., Kim, N. W., Prowse, K. R., Weinrich, S. L., Hirsch, K. S., West, M. D., Bacchetti, S., Hirte, H. W., Counter, C. M., Greider, C. W., et al. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.035 · Cited by 396
Chiu, C., Dragowska, W., Kim, N. W., Vaziri, H., Yui, J., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1996) · STEM CELLS · doi:10.1002/stem.140239 · Cited by 388
Piatyszek, M. A., Kim, N. W., Weinrich, S. L., Hiyama, K., Hiyama, E., Wright, W. E., & Shay, J. W. (1995) · Methods in Cell Science · doi:10.1007/bf00981880 · Cited by 384
Regulation of Telomerase Activity in Immortal Cell Lines
Holt, S. E., Wright, W. E., & Shay, J. W. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.2932 · Cited by 361
Counter, C. M., Botelho, F. M., Wang, P., Harley, C. B., & Bacchetti, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.3410-3414.1994 · Cited by 355
Petzer, A. L., Hogge, D. E., Landsdorp, P. M., Reid, D. S., & Eaves, C. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1470 · Cited by 350
Involvement of p34cdc2 in establishing the dependency of S phase on mitosis
Broek, D., Bartlett, R., Crawford, K., & Nurse, P. (1991) · Nature · doi:10.1038/349388a0 · Cited by 337
Petzer, A. L., Zandstra, P. W., Piret, J. M., & Eaves, C. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2551 · Cited by 317
The Role of p34 Kinases in the G1 to S-Phase Transition
Reed, S. I. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.002525 · Cited by 309
Cell cycle-dependent modulation of telomerase activity in tumor cells.
Zhu, X., Kumar, R., Mandal, M., Sharma, N., Sharma, H. W., Dhingra, U., Sokoloski, J. A., Hsiao, R., & Narayanan, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6091 · Cited by 226
Self-citationShah, A., Smogorzewska, E., Hannum, C., & Crooks, G. (1996) · Blood · doi:10.1182/blood.v87.9.3563.bloodjournal8793563 · Cited by 214
Tsuji, K., Lyman, S., Sudo, T., Clark, S., & Ogawa, M. (1992) · Blood · doi:10.1182/blood.v79.11.2855.2855 · Cited by 158
Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas
Norrback, K., Dahlenborg, K., Carlsson, R., & Roos, G. (1996) · Blood · doi:10.1182/blood.v88.1.222.222 · Cited by 156
Telomere length and proliferation potential of hematopoietic stem cells
Lansdorp, P. M. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.1.1 · Cited by 118
Telomere shortening in renal cell carcinoma.
Mehle, C., Ljungberg, B., & Roos, G. (1994) · PubMed · Cited by 105
Albanell, J., Han, W., Mellado, B., Gunawardane, R. N., Scher, H. I., Dmitrovsky, E., & Moore, M. A. S. (1996) · PubMed · Cited by 105
Self-citationFlasshove, M., Banerjee, D., Mineishi, S., Li, M., Bertino, Jr., & Moore, M. (1995) · Blood · doi:10.1182/blood.v85.2.566.566 · Cited by 96
Self-citationKumar, R., & Atlas, I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6599 · Cited by 94
Self-citationFLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver
Muench, M. O., Roncarolo, M., Menon, S., Xu, Y., Kastelein, R., Zurawski, S., Hannum, C., Culpepper, J., Lee, F., & Namikawa, R. (1995) · Blood · doi:10.1182/blood.v85.4.963.bloodjournal854963 · Cited by 94
Ex vivo expansion of cord blood-derived stem cells and progenitors.
Ma, M., & Hoskins, I. (1994) · PubMed · Cited by 78
Developmental changes in the function of hematopoietic stem cells.
Lansdorp, P. (1995) · PubMed · Cited by 68
Lansdorp, P. M., & Dragowska, W. H. (1993) · PubMed · Cited by 61
Brousset, P., Saati, T. A., Chaouche, N., Zenou, R. C., Schlaifer, D., Chittal, S. M., & Delsol, G. (1997) · Blood · doi:10.1182/blood.v89.1.26 · Cited by 52
Hematopoietic reconstruction: new approaches.
Moore, M. A. S. (1995) · PubMed · Cited by 20
Self-citationIsolation and characterization of primitive hematopoietic progenitors of murine fetal liver.
Fujimoto, K., Lyman, S. D., Hiryama, F., & Ogawa, M. (1996) · PubMed · Cited by 15
Cited by
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Aubert, G., & Lansdorp, P. M. (2008) · Physiological Reviews · doi:10.1152/physrev.00026.2007 · Cited by 1,188
Calado, R. T., & Young, N. S. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0903373 · Cited by 754
Immune activation and inflammation in HIV‐1 infection: causes and consequences
Appay, V, & Sauce, D. (2008) · The Journal of Pathology · doi:10.1002/path.2276 · Cited by 743
Telomere Length in Epidemiology: A Biomarker of Aging, Age-Related Disease, Both, or Neither?
Sanders, J. L., & Newman, A. B. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxs008 · Cited by 537
Metadata
- Authors
- Engelhardt, M., Kumar, R., Albanell, J., Pettengell, R., Han, W., & Moore, M. A. S.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1997-07-01
- Volume
- 90
- Issue
- 1
- Pages
- 182-193
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W176973267
- Cited by
- 297
- References
- 44
- FWCI
- 12.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.